Interaction of plasma lipoproteins with human platelets - PubMed (original) (raw)
- PMID: 6331546
Free article
Interaction of plasma lipoproteins with human platelets
L K Curtiss et al. Blood. 1984 Aug.
Free article
Abstract
Human plasma low density lipoproteins (LDL) and high density lipoproteins (HDL) were radioiodinated and their interaction with washed human platelets was assessed. Both ligands were bound by the platelet at 37 degrees C, and an apparent equilibrium was attained within two hours. Minimal binding was observed at 22 degrees C or 4 degrees C. The specificity of these interactions was indicated by the observations that: (a) labeled and nonlabeled lipoproteins interacted with the platelet with the same apparent affinity; (b) nonlabeled lipoproteins inhibited binding, whereas unrelated plasma proteins did not; and (c) the platelet-bound ligands exhibited the appropriate apoprotein chain compositions when analyzed by polyacrylamide gel electrophoresis. Binding of HDL and LDL was found to be independent of the state of platelet activation and did not require divalent ions. Binding of HDL to the platelet was saturable, and a class of sites that maximally bound 1,585 +/- 390 HDL particles, with a dissociation constant of 3.1 X 10(-8) mol/L, was identified. Binding of LDL to the platelet was more complex, but evidence for a class of sites that bound 7,075 +/- 4,800 LDL particles, with a dissociation constant of 4 X 10(-8) mol/L, was found. LDL was a poor inhibitor of 125I-HDL binding to the platelet, whereas HDL was an effective inhibitor of 125I-LDL binding. The capacity of HDL to bind or inhibit LDL binding was not dependent on its apoprotein E content. These results are most readily interpreted in terms of two types of lipoprotein interaction sites on platelets: (1) an HDL binding site that does not bind or interacts poorly with LDL, and (2) an LDL binding site that recognizes or is otherwise altered by HDL. The HDL site may be similar to the HDL receptor expressed by steroidogenic tissues in terms of apoprotein specificity. The LDL site is not the same as the LDL receptor of most extrahepatic cells.
Similar articles
- Characterization of high density lipoprotein binding to human adipocyte plasma membranes.
Fong BS, Rodrigues PO, Salter AM, Yip BP, Despres JP, Angel A, Gregg RE. Fong BS, et al. J Clin Invest. 1985 Jun;75(6):1804-12. doi: 10.1172/JCI111893. J Clin Invest. 1985. PMID: 2989332 Free PMC article. - Lipoprotein binding to canine hepatic membranes. Metabolically distinct apo-E and apo-B,E receptors.
Hui DY, Innerarity TL, Mahley RW. Hui DY, et al. J Biol Chem. 1981 Jun 10;256(11):5646-55. J Biol Chem. 1981. PMID: 6263887 - Etofibrate increases binding of low and high density lipoprotein to human platelets of patients with type II hyperlipoproteinemia.
Virgolini I, Koller E, Li S, Yang Q, Banyai M, Rauscha F, Pidlich J, Pirker W, Sinzinger H. Virgolini I, et al. Atherosclerosis. 1993 Sep;102(2):217-26. doi: 10.1016/0021-9150(93)90164-p. Atherosclerosis. 1993. PMID: 8251008 - Receptor binding activity of high-density lipoproteins containing apoprotein E from abetalipoproteinemic and normal neonate plasma.
Innerarity TL, Bersot TP, Arnold KS, Weisgraber KH, Davis PA, Forte TM, Mahley RW. Innerarity TL, et al. Metabolism. 1984 Feb;33(2):186-95. doi: 10.1016/0026-0495(84)90133-1. Metabolism. 1984. PMID: 6319954 - Low-density lipoprotein and its effect on human blood platelets.
Relou IA, Hackeng CM, Akkerman JW, Malle E. Relou IA, et al. Cell Mol Life Sci. 2003 May;60(5):961-71. doi: 10.1007/s00018-003-2249-y. Cell Mol Life Sci. 2003. PMID: 12827283 Free PMC article. Review.
Cited by
- Secretory phospholipase A2 modified HDL rapidly and potently suppresses platelet activation.
Curcic S, Holzer M, Pasterk L, Knuplez E, Eichmann TO, Frank S, Zimmermann R, Schicho R, Heinemann A, Marsche G. Curcic S, et al. Sci Rep. 2017 Aug 14;7(1):8030. doi: 10.1038/s41598-017-08136-1. Sci Rep. 2017. PMID: 28808297 Free PMC article. - Scavenger receptor BI: a multi-purpose player in cholesterol and steroid metabolism.
Hoekstra M, Van Berkel TJ, Van Eck M. Hoekstra M, et al. World J Gastroenterol. 2010 Dec 21;16(47):5916-24. doi: 10.3748/wjg.v16.i47.5916. World J Gastroenterol. 2010. PMID: 21157967 Free PMC article. Review. - RNA-mediated regulation of Receptor-Ck gene in human platelets.
Singh J, Kaul D. Singh J, et al. Mol Cell Biochem. 1997 Aug;173(1-2):189-92. doi: 10.1023/a:1006872904778. Mol Cell Biochem. 1997. PMID: 9278271 - Receptor-'Ck' dependent signalling regulates the LDL-receptor gene transcription.
Goel R, Singh J, Kaul D. Goel R, et al. Mol Cell Biochem. 1997 Apr;169(1-2):79-83. doi: 10.1023/a:1006806118493. Mol Cell Biochem. 1997. PMID: 9089634 - Decreased capacity to inhibit platelet hyperactivity and to stabilize prostacyclin of high-density lipoproteins in experimental diabetes.
Ginon I, Talussot C, Ponsin G, Ciavatti M. Ginon I, et al. Acta Diabetol. 1995 Oct;32(3):170-5. doi: 10.1007/BF00838487. Acta Diabetol. 1995. PMID: 8590786